Meanwhile, the level of S100A12 also decreased, however not statistically significantly, indicating the predominance of pro-GN and PTX3 assessments in evaluating the beneficial effect of corticosteroid therapy in the course of Crohn’s disease. This evidence concerns the gene S100A12 and Crohn disease.